T1D Exchange Launches an Online Registry for People with Type 1 Diabetes
BOSTON –T1D Exchange today announced the official launch of the T1D Exchange Registry, an online longitudinal database of people living…
The Case for Flexible Work Schedules
COVID-19 has completely changed the way Americans live, work, and play. The pandemic has sent over 100 million people home to work in a safe, socially-distanced way.
Flexible work schedules could afford us time and space to make thoughtful management decisions for our diabetes.
Managing a Young Life With Diabetes, and Riding Through Challenges
Morgan Panzirer doesn’t remember much of a time before she had type 1 diabetes – she was diagnosed at 6 years old. Despite the physical and emotional toll the disease can exact – one that many of us are thoroughly familiar with – Morgan has been able to channel the struggles and the unique experiences of T1D into some truly remarkable opportunities.
Preliminary Findings from the T1D Exchange COVID-19 Study
Important preliminary findings from the T1D Exchange multi-center surveillance study on people with T1D and COVID-19 were published this week in the Diabetes Care journal.
Moving the Needle on the High-Risk T1D Patient – Lessons and Perspectives from the T1D Exchange Quality Improvement Collaborative
The T1D Exchange Quality Improvement Collaborative (QIC) is a T1D learning health system that includes over 10 endocrinology centers nationwide, working collaboratively on a shared goal of improving outcomes for people with T1D. The program is coordinated by the QI team at T1D Exchange in Boston.
“You Don’t Know When the Sugar’s Going to Kick In” – T1D Exchange Research on Managing Diabetes During a Marathon
The T1D Exchange outcomes research team worked with Beyond Type 1 and runners in the New York City Marathon to examine the effects and management of type 1 diabetes while engaged in long-distance endurance running.
T1D Exchange to Present Ten Studies Focused on Quality Improvement, Population Health and Real-World Evidence in Type 1 Diabetes at 80th American Diabetes Association Scientific Sessions
BOSTON–(BUSINESS WIRE)–T1D Exchange today announced that it will share data from ten abstracts, including six late breaking, focused on quality improvement, population health and real-world evidence and outcomes of people living with type 1 diabetes (T1D) at the American Diabetes Association (ADA) 80th Scientific Virtual Sessions. Two posters from the organization’s Quality Improvement Collaborative were recognized by healthcare information firm Close Concerns in its list of Top 50 Most Notable Posters.
Preliminary Findings of T1D Exchange’s Population Health Surveillance Study of COVID-19 in Individuals with Type 1 Diabetes Published in Diabetes Care
Preliminary results of our population health surveillance study, “Type 1 Diabetes and COVID-19: Preliminary Findings from a Multi-Center Surveillance Study in the United States,” were recently published in Diabetes Care, the peer-reviewed medical journal of the American Diabetes Association. The study focuses on individuals with type 1 diabetes (T1D) who are suspected or confirmed to have contracted Coronavirus Disease 2019 (COVID-19). This is the first U.S. based, multi-center study to examine patient characteristics and adverse outcomes among individuals with confirmed or suspected COVID-19.
A Message from Our CEO
We are deeply saddened to observe the recent needless loss of innocent life of George Floyd, and the pain it has inflicted on communities throughout our country. While we have recently been focused on the challenges posed by the global COVID-19 pandemic, including its disproportionate impact on people of color, this recent tragedy has only exacerbated these challenges.
The Role of Non-Profits and Telemedicine in T1D Care During the COVID-19 Pandemic
Individuals with diabetes type 1 are impacted by significant injustices, geographical disparities, and inequities. These are difficult truths – but not ones we have to be resigned to.
Check out this fascinating dive into the potential of virtual clinics, telemedicine, and innovative nonprofit strategies from one of our partners at The Helmsley Charitable Trust.
Join our mailing list for more about T1D